Login to Your Account



Other News To Note


Wednesday, March 14, 2012

• Valeant Pharmaceuticals International Inc., of Mississauga, Ontario, signed an agreement to acquire some assets from Gerot Lannach, an Austrian branded generics pharmaceutical company. Valeant will pay an amount equivalent to less than three times the sales of the assets, with up to $20 million in prospective milestone payments based on performance.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription